Table 3.

Adverse events (N = 30).

AEs	All Grades n (%)	Grade 1 n (%)	Grade 2 n (%)	Grade 3 n (%)	Grade 4 n (%)
Hematologic
Thrombocytopenia	2(6.7)	1(3.3)	0	0	1(3.3)
Anemia	2(6.7)	2(6.7)	0	0	0
Leukopenia	3(10.0)	2(6.7)	1(3.3)	0	0
Nonhematologic
Hypertension	22(73.3)	9(30.0)	9(30.0)	4(13.3)	0
Proteinuria	22(73.3)	15(50.0)	4(13.3)	3(10.0)	–
Hand-foot syndrome	27(90.0)	11(36.7)	13(43.3)	3(10.0)	–
Fatigue	25(83.3)	22(73.3)	2(6.7)	1(3.3)	–
Pain	17(56.7)	11(36.7)	5(16.7)	1(3.3)
Apositia	10(33.3)	9(30.0)	1(3.3)	0(0.0)	0(0.0)
Nausea/vomiting	7(23.3)	6(20.0)	1(3.3)	0(0.0)	0(0.0)
Rash	3(10.0)	1(3.3)	1(3.3)	1(3.3)	0(0.0)
Mucositis	15(50.0)	9(30.0)	5(16.7)	1(3.3)	0(0.0)
Dizzy	8(26.7)	8(26.7)	0(0.0)	–	–
Elevated transaminase	6(20.0)	5(16.7)	1(3.3)	0(0.0)	0(0.0)
Hemorrhage	3(10.0)	3(10.0)	0	0(0.0)	0(0.0)
Fever	1(3.3)	1(3.3)	0	0(0.0)	0(0.0)
Abdominal distension	4(13.3)	3(10.0)	1(3.3)	0(0.0)	0(0.0)
Diarrhea	3(10.0)	3(10.0)	0(0.0)	0(0.0)	0(0.0)

AEs, adverse events.

Hemorrhage: Oral bleeding (1), Vaginal bleeding (1), Bleeding from a breast mass (1).